In a nutshell This study aimed to investigate if first-line ibrutinib treatment was safe and effective in the long-term for patients with chronic lymphocytic leukemia. This study concluded that single-agent ibrutinib provided good outcomes for patients when compared to the standard treatment chlorambucil in...
Read MoreGenetic tests that came out positive-P53 mutations Posts on Medivizor
